National Association of Testing Authorities, Australia
Scope of Accreditation
Douglass Hanly Moir Pathology
Sonic Healthcare Pty Ltd
Site
North Ryde Laboratory
Accreditation No.
2178
Site No.
2171
Date of Accreditation
16 Apr 1987
Contact
Ms Tuyen Chieu
P: +61 (02) 98556042
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Anatomical Pathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue; Fresh tissue; Smears | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in-situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue; Smears; Tissue imprint | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Fresh tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Fixed cytological smears; Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Frozen tissue | Detection of antigenic targets - Various |
CAL/Biochemistry
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Renal calculi | Calcium |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma | Ethanol |
| Chemical pathology - Biogenic amines | Urine | 4-Hydroxy-3-methoxymethamphetamine (HMMA); 5-Hydroxyindoleacetic acid (5-HIAA); Adrenaline; Dopamine; Noradrenaline |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Sirolimus; Tacrolimus |
| Serum | Gentamicin (cidomycin, septopal, genticyn, garamycin); Phenobarbitone; Theophylline; Tobramycin; Vancomycin | |
| Carbamazepine; Digoxin; Lithium; Phenytoin (dilantin); Valproate (valproic acid, epilim) | ||
| Carbamazepine; Gentamicin (cidomycin, septopal, genticyn, garamycin); Phenobarbitone; Phenytoin (dilantin); Primidone; Theophylline; Tobramycin; Valproate (valproic acid, epilim); Vancomycin | ||
| Serum; Urine | Nicotine | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Serum | Thyroglobulin |
| CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9) | ||
| CA125 antigen (CA125); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); Prostate specific antigen (PSA) fractions and derived index; α-Fetoprotein (AFP) | ||
| Human epididymal protein 4 | ||
| Human chorionic gonadotropin (hCG) | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Serum | Adrenocorticotropic hormone (ACTH); Cortisol; Gastrin; Growth hormone |
| Parathyroid hormone (PTH); Procalcitonin; Prolactin; Sex hormone binding globulin (SHBG); Testosterone | ||
| 17α-Hydroxyprogesterone; Androstenedione | ||
| Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Oestradiol; Progesterone | ||
| Urine | Cortisol | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Serum | Fructosamine | |
| Chemical pathology - Further investigation of cardiac function | Serum | Troponin T |
| Creatine kinase MB (CKMB) | ||
| Troponin I | ||
| N-Terminal-pro b-type natriuretic peptide (NT-proBNP) | ||
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Serum | HDL - Quantitation; Lipoprotein subclasses |
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Bile acids - Quantitative |
| Caeruloplasmin; Haptoglobins; α1-Antitrypsin | ||
| Alkaline phosphatase (ALP) isoenzymes | ||
| Lactate dehydrogenase (LDH) isoenzymes | ||
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Serum; Urine | Myoglobin |
| β2-Microglobulin (B2M) | ||
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Protein - Total |
| Cerebrospinal fluid (CSF); Serum | Angiotensin converting enzyme (ACE) | |
| Drainage fluid; Pleural fluid | Amylase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Protein - Total; Urate | |
| Plasma | Glucose | |
| Ammonia; Lactate | ||
| Serum | Angiotensin converting enzyme (ACE) | |
| Bilirubin - Any fractions; Cholinesterase; Creatinine | ||
| Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - LDL; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | ||
| Serum; Urine | Osmolality | |
| Urine | Amylase | |
| Albumin; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | ||
| Chemical pathology - Investigation for folate deficiency | Blood | Red blood cell folate |
| Serum | Folate | |
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | C14 |
| Chemical pathology - Investigation of malabsorption | Faeces | Faecal fat |
| Chemical pathology - Iron studies | Blood | Zinc protoporphyrin (ZPP) |
| Serum | Iron; Transferrin; Transferrin - Iron saturation percentage (%) | |
| Ferritin | ||
| Transferrin receptor (TFR) | ||
| Chemical pathology - Markers of bone metabolism | Urine | Deoxypyridinoline (DPD) |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma | Homocysteine |
| Chemical pathology - Quantitation of vitamin B markers | Serum | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Serum | 25-Hydroxyvitamin D3 |
| Cobalamin (vitamin B12) | ||
| Vitamin D | ||
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Chemical pathology - Trace element analysis | Blood | Lead |
| Serum | Copper; Zinc | |
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Rheumatoid factor |
| Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) | ||
| Anti-double stranded DNA antibodies (dsDNA) | ||
| Anti-thyrotropin receptor antibodies (TSHR) | ||
| Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin; Elastase |
| Serum | Detection and quantitation of free kappa and free lambda light chains | |
| Serum; Urine | Protein classes | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Immunoglobulin subclasses | ||
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
| Urine | Human chorionic gonadotropin (hCG) - Quantitative total | |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Faeces | Helicobacter pylori |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Anti-streptolysin O (ASOT) |
Cytopathology
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical smear; Cervical tissue; Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Endometrial pipelle; Liquid based cytology specimens from cervix; Vaginal smears; Vaginal tissue; Vault smears; Vulval smears | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Ocular specimens; Other body fluids; Sputum; Urine; Vitreous specimens; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program | Liquid based cytology specimens from cervix | Human papilloma virus (HPV); Cytological examination; Review and reporting of cervical cytological material |
| Self collected swab samples | Human papilloma virus (HPV) |
Division of Toxicology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | Synthetic cannabis |
| 6-Acetylmorphine; Buprenorphine; Codeine; Fentanyl; Morphine; Opiates; Opioids; Oxycodone; Oxymorphone; Propoxyphene; Tramadol | ||
| Buprenorphine; Methadone; Oxycodone; Phencyclidine; Propoxyphene |
ISO/IEC 17025 (2017)
Legal
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308:2008, appendix A On-site screening procedure - Testing performed at client sites | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Opiates |
| Medico legal drug testing AS/NZS 4308:2008, section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Creatinine; Temperature; pH |
| Medico legal drug testing AS/NZS 4308:2008, section 3 General laboratory requirements | Urine | General laboratory requirements as described in AS/NZS 4308 |
| Medico legal drug testing AS/NZS 4308:2008, section 4 Laboratory screening procedures | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Urea; pH |
| Medico legal drug testing AS/NZS 4308:2008, section 5 Laboratory confirmatory procedures | Urine | 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Diazepam; Nordiazepam; Oxazepam; Temazepam; α-Hydroxyalprazolam |
| 11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Amphetamines; Benzoylecgonine (ecgonine benzoate); Codeine; Ecgonine methyl ester; Ephedrine; Fentanyl; Methylamphetamine; Morphine; Oxycodone; Oxymorphone; Phentermine; Propoxyphene; Pseudoephedrine (PSE); Tramadol | ||
| Medico legal drug testing AS/NZS 4760, appendix A On-site screening test procedure | Oral fluid | Amphetamine type substances; Cocaine; Cocaine metabolites; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
| Medico legal drug testing AS/NZS 4760, appendix B Additional testing | Oral fluid | Benzodiazepines |
| Medico legal drug testing AS/NZS 4760, section 2 Collection, storage, handling and dispatch | Oral fluid | Handling and dispatch; Sample collection and storage |
| Medico legal drug testing AS/NZS 4760, section 3 General laboratory requirements | Oral fluid | General laboratory requirements as described in AS/NZS 4760 |
| Medico legal drug testing AS/NZS 4760, section 4 Laboratory screen testing | Oral fluid | Amphetamine type substances; Cocaine; Cocaine metabolites; Opiates; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
| Medico legal drug testing AS/NZS 4760, section 5 Laboratory confirmatory procedures | Oral fluid | 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Alprazolam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Clonazepam; Cocaine; Codeine; Diazepam; Ecgonine methyl ester; Methylamphetamine; Morphine; Nitrazepam; Nordiazepam; Oxazepam; Oxycodone; Temazepam; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
Eastwood Collection Centre
ISO/IEC 17025 (2017)
Legal
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308:2008, appendix A On-site screening procedure | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Opiates |
| Medico legal drug testing AS/NZS 4760, appendix A On-site screening test procedure | Oral fluid | Amphetamine type substances; Cocaine; Cocaine metabolites; Opiates; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
Faecal Occult Blood Testing Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of tumour markers - Testing for the National Bowel Cancer Screening Program | Faeces | Blood |
Haematology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Diagnosis of thalassemia | Blood | Haemoglobin H (HbH) inclusions |
| Haemoglobin A2 (HbA2) - Quantitation | ||
| Haematology - Examination of blood films by special staining | Blood | Morphology |
| Heinz bodies | ||
| Malaria; Parasites | ||
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Presence of foetal red blood cells |
| Detection and quantitation of foetal red cell antigens | ||
| Haematology - Full blood examination | Blood | Reticulocytes |
| Morphology | ||
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Nucleated red blood cells (NRBC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| Plasma | Factor XIII | |
| Collagen binding activity | ||
| Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa - Dabigatran; Anti-Xa activity; Anti-thrombin III; D-dimer; Factor II; Factor IX; Factor IX inhibitor; Factor V; Factor VII; Factor VIII; Factor VIII inhibitor; Factor X; Factor XI; Factor XII; Factor XIII; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Protein C and protein S; Prothrombin time (PT); Thrombin time (TT); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | ||
| Serum | Heparin induced thrombotic thrombocytopenia (HITT) | |
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence |
| Other abnormal haemoglobins | ||
| Haematology - Investigation of haemolysis | Blood | Paroxysmal nocturnal haemoglobinuria (PNH) screen |
| Urine | Haemosiderin | |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Aspirates; Blood; Bone marrow; Disaggregated tissues specimen | 7-Aminoactinomycin (7-AAD); Assessment of lymphoid cell populations; Assessment of myeloid cell populations; CD10; CD103; CD117; CD11b; CD11c; CD123; CD13; CD138; CD14; CD15; CD158a; CD158b; CD158e; CD158k; CD16; CD161; CD19; CD2; CD20; CD23; CD24; CD25; CD27; CD28; CD3; CD300e (IREM-2); CD34; CD38; CD4; CD45; CD5; CD56; CD57; CD59; CD64; CD7; CD8; CD94; Fluorescein-labelled proaerolysin (FLAER); HLA-DR antigen; Kappa light chains; Lambda light chains; Natural killer (NK) cells; T-cell receptor aβ (TCRab); γ,δ-T-cell receptor |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Plasmodium falciparum; Plasmodium vivax |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
Immunohaematology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Haematology - Investigation of haemolysis | Blood | Cold agglutinins |
| Immunohaematology - Blood group antibody detection | Blood | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody titration |
| Antibody elution | ||
| Other blood group antibodies; Red blood cell phenotyping; Rh | ||
| Direct antiglobulin test (DAT, direct Coombs test) |
Immunoserology
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Tryptase |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-endomysial antibodies (EMA); Anti-intercellular cement substance IgG antibodies; Anti-liver-kidney microsomes antibodies (LKM); Anti-neuronal antibodies; Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA); Anti-skin basement membrane antibodies |
| Anti-intrinsic factor antibodies (IF) | ||
| Anti-cyclic citrullinated peptide antibodies (CCP) | ||
| Anti-Saccharomyces cerevisiae antibodies (ASCA) | ||
| Anti-extractable nuclear antigen antibodies (ENA); Anti-ganglioside antibodies; Anti-inclusion body myositis (IBM) antibodies; Anti-liver antibodies; Anti-myositis antibodies; Anti-neuronal antibodies | ||
| Bullous dermatoses | ||
| Anti-cardiolipin antibodies (ACA); Anti-chromatin antibodies; Anti-extractable nuclear antigen antibodies (ENA); Anti-gliadin antibodies (AGA); Anti-glomerular basement membrane antibodies (anti-GBM); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG); Anti-β2-glycoprotein-I antibodies | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing (purified native and/or recombinant allergens)) | Serum | Api m1 phospholipase A2 - Honey bee; Ara h1 - Peanut; Ara h2 - Peanut; Ara h3 - Peanut; Ara h8 - Peanut; Ara h9 - Peanut; Casein - Milk; Galactose-α-1,3-galactose thyroglobulin - Bovine; MUXF3 CCD; Omega-5-gliadin - Wheat; Ovomucoid - Egg; α-Lactalbumin - Milk; β-Lactoglobulin - Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Tetanus toxoid; Amoxicillin; Ampicilloyl group; Cefaclor; Chlorhexidine; Chymopapain; Gelatin - Bovine; Insulin - Human; Morphine; Penicilloyl G; Penicilloyl V; Pholcodine; Suxamethonium (succinylcholine) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Cat epithelium; Djungarian hamster; Dog epithelium; Goat epithelium; Guinea pig epithelium; Horse epithelium; Male dog urine; Mouse epithelium; Pigeon tick; Rabbit epithelium; Sheep epithelium; Swine epithelium |
| Animal mix; Budgerigar droppings; Budgerigar feathers; Budgerigar serum; Caged bird mix; Canary bird droppings; Canary bird feathers; Canary bird serum; Cat epithelium; Cat serum; Chicken droppings; Chicken feathers; Chicken serum proteins; Cow dander; Dog dander; Dog epithelium; Dog serum; Duck feathers; Feather mix; Finch feathers; Goat epithelium; Goose feathers; Guinea pig epithelium; Hamster epithelium; Horse dander; Mouse epithelium; Mouse serum proteins; Mouse urine proteins; Parakeet droppings; Parakeet feathers; Parakeet serum; Parrot feathers; Pigeon droppings; Pigeon feathers; Rabbit epithelium; Rabbit urine proteins; Rat epithelium; Rat serum proteins; Rat urine proteins; Sheep epithelium; Swine epithelium; Swine serum; Turkey feathers | ||
| Cat dander; Cat epithelium; Dog dander; Dog epithelium; Horse dander; Horse epithelium; Mouse epithelium; Mouse serum proteins; Mouse urine proteins | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [additives] allergens) | Serum | Carob (E410); Cochineal extract (carmine red, E120) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg; Egg white; Egg yolk; Turkey meat |
| Chicken; Egg; Egg white; Egg yolk | ||
| Chicken; Egg white; Egg yolk; Turkey meat | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Abalone; Anchovy; Blue mussel; Catfish; Chub mackerel; Clam; Codfish; Crab; Crayfish; Eel; Grouper; Gulf flounder; Haddock; Hake; Halibut; Herring; Jack mackerel; Langust (spiny lobster); Lobster; Mackerel; Megrim; Octopus; Orange roughy; Oyster; Pollock; Prawn; Red snapper; Salmon; Sardine (pilchard); Scallop; Seafood mix; Shrimp; Snail; Sole; Squid; Swordfish; Tilapia; Trout; Tuna; Walleye pike; Whitefish (Inconnu) |
| Codfish; Shrimp | ||
| Anisakis; Atlantic cod; Atlantic mackerel; Black tiger shrimp; Blue mussel; Brown shrimp; Carp; Clam; Crab; Eel; Grouper; Gulf flounder; Herring; Lobster; Orange roughy; Oyster; Plaice; Salmon; Shrimp; Squid; Swordfish; Thornback ray; Tuna | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Avocado; Banana; Blueberry; Carrot; Celery; Cherry; Fig; Garlic; Grape; Kiwi; Mango; Melon; Onion; Orange citrus; Papaya; Peach; Pear; Potato; Strawberry; Tomato |
| Apple; Apricot; Asparagus; Aubergine (eggplant); Avocado; Bamboo shoot; Banana; Beetroot; Blackberry; Blueberry; Broccoli; Brussel sprouts; Cabbage; Carrot; Cauliflower; Celery; Cherry; Cucumber; Date; Fig; Fruit mix; Garlic; Grape; Grapefruit; Jack fruit; Kiwi; Lemon citrus; Lettuce; Lime citrus; Lychee; Mandarin (tangerine, clementine, satsumas) citrus; Mango; Melon; Olive - Black, fresh; Onion; Orange citrus; Papaya; Passion fruit; Peach; Pear; Persimon (kaki fruit, sharon); Pineapple; Plum; Potato; Pumpkin; Raspberry; Red currant; Rose hip; Spinach; Strawberry; Sweet potato; Tomato; Vegetable mix; Watermelon | ||
| Apple; Celery; Kiwi; Peach | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Galactose-α-1,3-galactose thyroglobulin - Bovine |
| Beef; Galactose-α-1,3-galactose thyroglobulin - Bovine; Horse; Lamb; Meat mix; Pork; Rabbit | ||
| Beef; Horse; House cricket; Lamb; Mealworm; Migratory locust; Mutton; Pork; Rabbit | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Cow milk |
| Casein; Cheese - Cheddar type; Cheese - Mould type; Cow’s whey; Goat milk; Milk; Sheep milk; Sheep whey | ||
| Camel milk; Cow milk; Goat milk; Horse milk; Sheep milk | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Baker's yeast; Brewer’s yeast; Cacao; Chocolate; Coffee; Honey; Hop (fruit cone); Malt; Mushroom; Staple food mix; Tea; Yeasts |
| Yeasts | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Barley; Brazil nut; Buck wheat; Cashew nut; Chick pea; Common millet; Fenugreek; Hazelnut; Lentil; Lupin seed; Macadamia nut; Maize; Oat; Pea; Peanut; Pecan nut; Pistachio; Poppy seed; Pumpkin seed; Quinoa; Rice; Rye; Sesame seed; Soy bean; Spelt wheat; Sugar-beet seed; Sunflower seed; Walnut; Wheat; White bean |
| Brazil nut; Buck wheat; Cashew nut; Hazelnut; Peanut; Sesame seed; Soy bean; Walnut; Wheat | ||
| Almond; Barley; Brazil nut; Buck wheat; Cashew nut; Cereal mix; Chick pea; Coconut; Common millet; Corn; Fenugreek; Foxtail; Gluten; Green bean; Hazelnut; Japanese millet; Lentil; Lima bean; Linseed; Lupin seed; Macadamia nut; Nut panel; Oat; Pea; Peanut; Pecan nut; Pinenut; Pistachio; Poppy seed; Pumpkin seed; Quinoa; Rapeseed; Red kidney bean; Rice; Rye; Sesame seed; Soy bean; Spelt wheat; Sunflower seed; Walnut; Wheat; White bean | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [spices] allergens) | Serum | Anise; Caraway; Mustard; Oregano; Paprika (sweet pepper); Parsley |
| Allspice; Anise; Basil; Bay leaf; Black pepper; Cardamon; Chilli pepper; Cinnamon; Clove; Coriander (cilantro); Curry; Fennel seed; Ginger; Green pepper - Unripe seed; Lovage; Marjoram; Mint; Mustard; Oregano; Paprika (sweet pepper); Parsley; Saffron; Sage; Spice mix; Tarragon; Thyme; Vanilla | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Bermuda grass; Common reed; Cultivated rye; Perennial rye grass; Timothy grass |
| Bermuda grass; Timothy grass | ||
| Bahia grass; Bermuda grass; Brome grass; Canary grass; Couch grass; Cultivated oat; Cultivated rye; Cultivated wheat; Grass mix; Johnson grass; Kentucky plane (June) grass; Meadow fescue; Meadow foxtail; Perennial rye grass; Redtop; Salt grass; Sweet vernal grass; Timothy grass; Velvet grass; Wild rye grass | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | American cockroach; Fire ant; German cockroach |
| Cockroach | ||
| American cockroach; Berlin beetle; Blood worm; Cockroach; Fire ant; Grain weevil; Green nimitti; Horse fly Tabanus spp.; Mediterranean flour moth; Mosquito; Moth; Oriental cockroach | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Anisakis; Aspergillus fumigatus; Cladosporium herbarum |
| Alternaria alternata; Aspergillus fumigatus; Cladosporium herbarum; Malassezia spp.; Penicillium chrysogenum (formerly Penicillium notatum) | ||
| Acremonium kiliense; Alternaria alternata; Alternaria tenius; Anisakis; Ascaris spp. (roundworm); Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Aspergillus terreus; Aureobasidium pullulans; Botrytis cinerea; Candida albicans; Cladosporium herbarum; Curvularia lunata; Echinococcus spp.; Epicoccum purpurascens; Fusarium verticillioides (Fusarium moniliforme); Malassezia spp.; Mucor racemosus; Penicillium chrysogenum (formerly Penicillium notatum); Phoma betae; Pityrosporum orbiculare (Malassezia furfur); Rhizopus nigricans; Setomelanomma rostrata (Helminthosporium halodes); Staphylococcus enterotoxins; Stemphylium herbarum; Tilletia tritici; Trichoderma viride; Trichophyton interdigitale; Trichophyton rubrum; Trichosporon pullulans; Ulocladium chartarum | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential miscellaneous allergens) | Serum | Albumin - Bovine; Cotton; Fish feed; Lactoferrin - Bovine; Seminal fluid; Tobacco leaf |
| Lactoferrin - Hom s | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; Lepidoglyphus destructor storage mite |
| Acarus siro storage mite; Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides microceras house dust mite; Dermatophagoides pteronyssinus house dust mite; Euroglyphus mayne house dust mite; Glycyphagus domesticus storage mite; Lepidoglyphus destructor storage mite; Tyrophagus putrescentiae storage mite; House dust - Greer; House dust mite mix | ||
| Acarus siro storage mite; Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; Glycyphagus domesticus storage mite; Lepidoglyphus destructor storage mite; Tyrophagus putrescentiae storage mite | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Latex |
| Ficus spp.; Castor bean; Chloramine-T; Cotton seed; Formaldehyde/formalin; Green coffee bean; Hexamethylene diisocyanate (1,6-hexamethylene diisocyanate; 1,6-HDI); House dust; Inhalant panel; Latex; Maleic anhydride; Methylene diphenyl diisocyanate (MDI, isocyanate MDI, diphenylmethane diisocyanate); Mould mix; Oxirane (ethyleneoxide); Pepsin; Phthalic anhydride; Psyllium (ispaghula); Rape (canola); Reactant chemicals mix; Silk; Silk waste; Tetrahydrophtalic anhydride; Toluene-2,4-diisocyanate (2,4-TDI); Trimellitic anhydride; Wool; α-Amylase | ||
| Latex | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; Alder; American beech; Australian pine; Box-elder; Cedar; Chestnut; Cottonwood; Cypress; Date; Elm; Eucalyptus; Horse chestnut; Italian/Mediterranean/funeral cypress; Japanese cedar; Melaleuca; Mountain cedar; Oak; Oil palm; Pine; Privet; Recombinant birch profilin; Red cedar; Silver birch; Sweet gum; Sycamore; Tree mix; Virginia live oak; Walnut; White ash; White pine; Willow salix |
| Alder; Cypress; Hazel; Japanese cedar; Olive; Plane tree; Silver birch | ||
| Acacia; Alder; Ash; Beech; Cottonwood; Cypress; Date; Elm; Hazel; Japanese cedar; London plane; Mountain cedar; Mulberry; Olive; Paper mulberry; Recombinant birch profilin; Red cedar; Silver birch; Tree of heaven ; Walnut; Weeping fig | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Common wasp (yellow jacket) venom; Honey bee venom; Paper wasp venom |
| Bee venom; Bumblebee venom; Common wasp (yellow jacket) venom; European hornet venom; European paper wasp venom; Honey bee venom; Paper wasp venom; White-faced hornet venom; Yellow hornet venom | ||
| Honey bee venom; Hornet venom; Paper wasp venom; Wasp venom | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Annual mercury; Common ragweed; Goosefoot; Mugwort; Plantain - English; Saltwort (prickly); Wall pellitory |
| Careless weed; Cocklebur; Common pigweed; Common ragweed; Dandelion; False ragweed; Flower mix; Giant ragweed; Goldenrod; Lamb’s quarters; Lupin; Mugwort; Ox-eye daisy; Plantain - English; Rough marshelder; Russian thistle; Scale; Sheep sorrel; Sunflower; Wall pellitory; Weed mix; Western ragweed; Wormwood | ||
| Annual mercury; Cocklebur; Common ragweed; False ragweed; Goosefoot; Hemp; Lamb’s quarters; Mugwort; Nettle; Plantain - English; Ragweed; Ribwort; Russian thistle; Saltwort (prickly); Wall pellitory | ||
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum | Eosinophil cationic protein |
| Cryofibrinogen; Cryoglobulins | ||
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin E |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody |
| Serum | Bordetella pertussis IgA; Bordetella pertussis IgG; Chlamydia trachomatis IgG antibody; Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Herpes simplex virus (HSV); Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Measles IgG antibody; Measles IgM antibody; Mumps virus IgG antibody; Mumps virus IgM antibody; Mycoplasma pneumoniae IgG antibody; Mycoplasma pneumoniae IgM antibody; Parvovirus B19 IgG antibody; Parvovirus B19 IgM antibody; Rubella IgM antibody; Varicella zoster virus (VZV) IgG antibody; Varicella zoster virus IgM antibody | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody | ||
| Syphilis Treponema pallidum antibody | ||
| Cytomegalovirus (CMV); Cytomegalovirus (CMV) IgG avidity; Cytomegalovirus antibody (anti-CMV) IgM; Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Quantitative; Hepatitis C virus (HCV); Hepatitis C virus antibody (anti-HCV); Human T-lymphotropic virus type I/II (HTLV-I/II); Human immunodeficiency virus (HIV); Rubella IgG antibody; Syphilis Treponema pallidum antibody; Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibody; Toxoplasma; Toxoplasma activity index | ||
| Barmah forest virus total antibody; Chlamydia spp.; Coxiella burnetii (Q-fever) total antibody; Dengue virus IgG antibody; Dengue virus IgM antibody; Dengue virus NS1 antigen; Ross River virus; Schistosoma mansoni | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgM antibody | ||
| Helicobacter pylori | ||
| Hepatitis C virus (HCV) | ||
| Cryptococcus spp. |
Microbiology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Morphology; Motility; Sperm number |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Bacteria; Pathogenic microorganisms |
| Blood | Bacteria; Cultured pathogens identification; Pathogenic microorganisms | |
| Bacteria; Cultured pathogens identification; Pathogenic microorganisms | ||
| Blood; Cerebrospinal fluid (CSF); Faeces; Fluids; Sputum; Tissues; Urine; Wound swabs | Bacteria; Pathogenic identification and antibiotic susceptibility | |
| Bacteria; Cultured pathogens identification; Pathogenic microorganisms | ||
| Bacteria; Pathogenic identification and antibiotic susceptibility | ||
| Blood; Cerebrospinal fluid (CSF); Fluids; Genital specimens; Nasal swabs; Pus; Sputum; Urine; Wound swabs | Bacteria; Pathogenic identification and antibiotic susceptibility | |
| Cerebrospinal fluid (CSF); Urine | Legionella antigen | |
| Streptococcus pneumoniae | ||
| Urine | Bilirubin; Blood; Glucose; Ketones; Leucocytes (white blood cells, WBC); Nitrite; Proteins; Urobilinogen; pH | |
| Bacteria; Pathogenic microorganisms | ||
| Microbiology - Environmental investigations and/or infection control | Spore strips | Bacterial growth - Sterility |
| Vascular catheter tips | Bacterial growth - Sterility | |
| Bacterial growth - Sterility | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Axilla swabs; Groin swabs | Methicillin resistant Staphylococcus aureus (MRSA); Methicillin susceptible Staphylococcus aureus (MSSA) |
| Nasal swabs | Methicillin resistant Staphylococcus aureus (MRSA); Methicillin susceptible Staphylococcus aureus (MSSA) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Blood | Mycobacteria identification |
| Mycobacteria identification | ||
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Isolates | Yeasts identification |
| Nails; Skin scrapings; Tissues | Fungi identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cryptosporidia; Giardia spp. |
| Cysts; Ova; Parasites | ||
| Cryptosporidia; Giardia spp. | ||
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Norovirus |
| Adenovirus; Rotavirus |
Molecular Biology
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Aspirates; Nasal swabs; Throat swabs | Bordetella pertussis |
| Faeces | Aeromonas spp.; Campylobacter spp.; Clostridium difficile toxin B; Escherichia coli - Enteroinvasive (EIEC); Salmonella spp.; Shigella spp.; Vibrio spp.; Yersinia enterocolitica | |
| Clostridioides difficile | ||
| Faeces; Fresh biopsy | Helicobacter pylori | |
| Genital swabs | Streptococcus agalactiae (Streptococcus group B) | |
| Genital swabs; Urine | Mycoplasma genitalium; Mycoplasma hominis; Ureaplasma parvum; Ureaplasma urealyticum; Azithromycin resistant Mycoplasma genitalium | |
| Mycoplasma genitalium; Macrolide resistant Mycoplasma genitalium | ||
| Liquid based cytology specimens; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Chlamydophila pneumoniae; Legionella pneumophila; Mycoplasma pneumoniae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Sputum | Mycobacterium tuberculosis |
| Tissues | Mycobacterium tuberculosis | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Blastocystis hominis; Cryptosporidium spp.; Cyclospora cayetanensis; Dientamoeba fragilis; Entamoeba histolytica; Giardia lamblianew kit and analyser FEB 2023 to be assessed at next RES. not note determinant C Cayetanensis. |
| Genital swabs | Trichomonas vaginalis | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Bronchoalveolar lavage; Nasal swabs; Nasopharyngeal and throat swab; Sputum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Combined nose and throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| General swabs; Genital swabs | Herpes simplex virus (HSV); Varicella zoster virus (VZV) | |
| Liquid based cytology specimens | Human papilloma virus (HPV) | |
| Liquid based swabs | Monkeypox virus | |
| Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs; Throat wash | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) A/B | |
| Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus | ||
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Plasma; Serum | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA | |
| Microbiology - Molecular biology - Surveillance programme for the detection of microbial nucleic acids (viruses) in accordance with Commonwealth and/or State Health protocols | Saliva; Saliva suck swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
Molecular Genetics
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Cytogenetics - Karyotype detection of balanced and/or unbalanced chromosome abnormalitiesAnalysis and reporting only (wet lab work performed by SNP - 01964 23038) | Blood | Acquired genetic abnormalities; Cytogenetic analysis and reporting; Haematological abnormalities |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Factor V Leiden; Haemochromatosis; Lactate persistence gene; Methylenetetrahydrofolate reductase (MTHFR); Prothrombin variant |
| Extracted DNA | HLA-B locus typing; HLA-DB locus typing; HLA-DR locus typing; Nucleic acid analysis for specific variants | |
| Nucleic acid analysis for specific variants | ||
| HLA-B locus typing; HLA-DB locus typing; HLA-DR locus typing; Nucleic acid analysis for specific variants | ||
| UGT1A1 genotyping | ||
| Fragile X syndrome (FRAXA); UGT1A1 genotyping | ||
| Cystic fibrosis | ||
| Thiopurine methyltransferase (TPMT) | ||
| Dihydropyrimidine dehydrogenase (DPYD) genotyping | ||
| JAK2 genotyping | ||
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted panels for inherited (germline) DNA/RNA changes | Extracted DNA | Cytochrome P450 pharmacogenomic studies; Nucleic acid analysis for specific variants |
| Molecular genetics - Bioinformatic analysis | DNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
| Molecular genetics - DNA extraction | Blood | Viable DNA for sequencing |
| Viable DNA | ||
| Viable DNA | ||
| Blood; Buccal swabs | Viable DNA | |
| Molecular genetics - DNA fragment size analysis | Fluorescent-labelled DNA sequencing reaction product | Cystic fibrosis; DNA fragment size determination; Fragile X; Triple repeat analysis; UGT1A1 genotyping; Y chromosome microdeletion |
| MLPA products | DNA fragment size determination | |
| Molecular genetics - DNA sequencing | Blood; Extracted DNA | Sequenced DNA utilising massively parallel sequencing technologies |
| Extracted DNA | Sequenced DNA by Sanger sequencing | |
| Molecular genetics - Estimation of risk of inheritance of an unknown mutation (Bayesian and linkage calculations) | Extracted DNA | Spinal muscular atrophy |
| Cystic fibrosis; Estimation of risk | ||
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood | Chronic myeloid leukaemia (CML) |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes | Formalin-fixed paraffin-embedded (FFPE) tissues | Copy number alterations (CNAs); Gene fusion; Genomic rearrangements; Indels; Microsatellite instability analysis; Single nucleotide variants (SNVs); Somatic mutation detection; Tumour mutation burden (TMB) |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Extracted DNA | Spinal muscular atrophy; α-Thalassaemia |
| Cystic fibrosis | ||
| Fragile X syndrome (FRAXA) | ||
| Spinal muscular atrophy | ||
| Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes | Extracted DNA | Familial Mediterranean fever; Hereditary angioedema; Tumour necrosis factor receptor associated periodic syndrome (TRAPS) |
| Spinal muscular atrophy | ||
| Fragile X syndrome (FRAXA) | ||
| Cystic fibrosis | ||
| Spinal muscular atrophy; α-Thalassaemia | ||
| Molecular genetics - Non-invasive prenatal (genetic) screening | Maternal blood | Rare autosome aneuploidy and segmental genomic imbalances |
| Aneuploidy for chromosomes X and Y; Jacobs syndrome (XYY); Kleinfelters syndrome (XXY); Rare autosome aneuploidy and segmental genomic imbalances; Trisomy 13, trisomy 18, trisomy 21; Trisomy X; Turners syndrome (SCA:XO) | ||
| Molecular genetics - Predictive genetic testing - Targeted genes | Blood | Cystic fibrosis; Inherited cancer syndromes |
| Extracted DNA | Spinal muscular atrophy | |
| Hereditary angioedema | ||
| Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes | Blood | Cystic fibrosis; Familial hypercholesterolemia; Hereditary breast and ovarian cancer syndrome; Hereditary colorectal cancer; Inherited cancer syndromes |
| Molecular genetics - Screening for an unknown mutation - Targeted genes | Blood; Extracted DNA | Ataxia telangiectasia (Louis Bar syndrome); Familial Mediterranean fever; Hereditary angioedema; Inherited cancer syndromes; Inherited disorders; Li-Fraumeni syndrome; Macrocephaly PTEN gene mutation; PTEN hamartoma tumour syndrome (PHTS); Peutz-Jeghers syndrome; Tumour necrosis factor receptor associated periodic syndrome (TRAPS) |
| Extracted DNA | Cystic fibrosis; Familial Mediterranean fever; Hereditary angioedema; Tumour necrosis factor receptor associated periodic syndrome (TRAPS) | |
| α-Thalassaemia | ||
| Molecular genetics - Screening for an unknown mutation - Targeted panels for inherited (germline) DNA/RNA changes | Blood; Extracted DNA | Ataxia telangiectasia (Louis Bar syndrome); Familial Mediterranean fever; Familial hypercholesterolemia; Hereditary colorectal cancer; Inherited cancer syndromes; Inherited disorders; Li-Fraumeni syndrome; Macrocephaly PTEN gene mutation; PTEN hamartoma tumour syndrome (PHTS); Peutz-Jeghers syndrome |
Prenatal Testing
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Serum | Free β-human chorionic gonadotropin (free β-hCG); Oestriol - Unconjugated; Placental growth factor (PGF, PLGF); Pregnancy associated plasma protein A (PAPP-A); α-Fetoprotein (AFP) |
Surge Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
01 Jun 2026
Last Activity Date
04 Jul 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2178
Site No.
2171
Print date
03 Dec 2023
END OF SCOPE
